Healthcare ❯ Pharmaceuticals ❯ Weight Loss Drugs ❯ GLP-1 Receptor Agonists

Oral Wegovy

Novo Nordisk Invests €432 Million to Expand Athlone Plant for Oral GLP-1 Tablets

The upgrade positions the site to supply markets outside the U.S. ahead of a possible EMA decision on the Wegovy pill.